DFE Pharma is a global leader in pharma- and nutraceutical excipient solutions. We develop, produce and supply high-quality functional excipients for use in the pharmaceutical, biopharmaceutical, and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients are used in numerous medicinal and nutraceutical products, including COVID-19 vaccines and treatments.
In our more than a century of heritage, we always work for customer satisfaction from formulation development support to excipient supply. We provide our customers with our comprehensive technical expertise and support to efficiently navigate any regulatory space.
DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives, driven by our purpose your medicines, our solutions. Moving to a healthier world.
A leading portfolio of premium quality excipients
We differentiate ourselves as a excipients supplier of choice through our track record and well-known reputation for quality and consistency. We offer a wide range of over 200 premium products that play an essential role as fillers, binders, disintegrants, carriers and stabilizers.
In the Biopharma field, our BioHale® portfolio is comprised by BioHale® Sucrose and BioHale® Trehalose Dihydrate, and can be used in various administration forms, such as for parenteral, inhalation, oral or ophthalmic route.
For Oral Solid Dose (OSD) formulations, we provide over 40 grades of milled-, sieved- and modified lactose, besides microcrystalline cellulose (MCC), superdisintegrants, starches and co-processed excipient solutions. We also develop customized blended forms.
As pioneers in the inhalation area, we produce a comprehensive range of lactose-based excipients, designed to offer the right characteristics for all inhaled medicines on the market. Furthermore, we can customize the lactose to meet the specific needs of our customers.
We also offer a comprehensive range of ingredients for nutraceutical products, comprising lactose including milled-, sieved-, anhydrous-, spray dried- and granulated lactose-, MCC, superdisintegrants, starches and multifunctional co-processed excipients.
Security of supply and technical support
We understand medicines and nutraceutical products are essential to patients and consumers and share our customers’ goal to deliver them in full and on time. To achieve this, we offer a Dual Sourcing system, meaning our products are produced at two different locations globally. So we can always be relied on the delivery of our products from one of our sites.
More than just a supplier, we are a partner in every phase of the product development and delivery. In this partnership we are constantly developing new services to support our pharmaceutical and nutraceutical companies with technical expertise, as well as with supply-, time to market- and risk mitigation services, striving always towards 100% reliability in our supply and premium quality.
Continuous innovation
Together with customers, suppliers and partners, we work towards the development of innovative products and transformative production methods, including 3D printing, Continuous Manufacturing and Biopharma solutions.
In May 2022, we open a new Closer to Formulator (C2F) Center of Excellence in India. This center supports the formulation or re-formulation of products, working with R&D teams of pharmaceutical companies globally. C2F enhances industry capabilities in excipient selection and formulation design, in line with the FDA’s ‘Quality-by-Design’ (QbD) mindset of integrating expertise and therefore quality into a product from the very start.
Global footprint
DFE Pharma is headquartered in Goch, Germany, and has around 450 DFE Pharma’s employees working worldwide. Currently, we operate 5 production locations (in the Netherlands, Germany, India and New Zealand) with access to a broader manufacturing network, and 7 sales offices to be close to customers, providing products and services to more than 5,000 customers in over 100 countries worldwide.
BIOPHARMA
BioHale® Sucrose
BioHale® Trehalose Dihydrate
INHALATION
Lactohale®
Lactohale® 100
Lactohale® 200
Lactohale® 201
Lactohale® 206
Lactohale® 210
Lactohale® 220
Lactohale® 230
Lactohale® 300
Respitose®
Respitose® ML001
Respitose® ML003
Respitose® SV001
Respitose® SV003
Respitose® SV010
Respitose® SV014
ORAL SOLID DOSE (OSD)
Milled and Sieved Lactose
Pharmatose®
Pharmatose® 50M
Pharmatose® 60M
Pharmatose® 70M
Pharmatose® 80M
Pharmatose® 90M
Pharmatose® 100M
Pharmatose® 110M
Pharmatose® 125M
Pharmatose® 130M
Pharmatose® 150M
Pharmatose® 200M
Pharmatose® 200M NZ
Pharmatose® 350M
Pharmatose® 350M NZ
Pharmatose® 450M
Lactochem®
Lactochem® Coarse Crystals
Lactochem® Crystals
Lactochem® Fine Crystals
Lactochem® Extra Fine Crystals
Lactochem® Coarse Powder
Lactochem® Powder
Lactochem® Regular Powder
Lactochem® Fine Powder
Lactochem® Extra Fine Powder
Lactochem® Super Fine Powder
Lactochem® Microfine
Modified Lactose
Supertab®
SuperTab® 11SD (spray dried)
SuperTab®® 11SD NZ (spray dried)
SuperTab® 14SD (spray dried)
SuperTab® 21AN (Anhydrous)
SuperTab® 22AN (Anhydrous)
SuperTab® 24AN (Agglomerated Anhydrous)
SuperTab® 30GR (Granulated)
SuperTab® 40LL (co-processed)
SuperTab® 50 ODT (Orally disintegrating tablets)
Lactopress®
Lactopress® Anhydrous
Lactopress® Anhydrous Fine Powder
Lactopress® Anhydrous Powder
Lactopress® Granulated
Lactopress® Spray Dried
Lactopress® Spray Dried 250
Superdisintegrants
Primojel®
Primellose®
Starches
Prejel PA5 PH
Solani Amylum
MCC
Pharmacel® 101
Pharmacel® 102
Pharmacel® 102
Pharmacel® 112
Pharmacel® sMCC 90
NUTRACEUTICALS
Nutracel™ 101 MCC
Nutracel™ 102
Pharmacel® 112
Pharmacel® sMCC 90
SuperTab® 11SD
SuperTab® 30GR
SuperTab® 21AN
SuperTab® 24AN
SuperTab® 40LL
SuperTab® 50 ODT
Pharmatose® 60M
Pharmatose® 100M
Pharmatose® 200M
Primojel®
Primellose®
Solani Amylum starch
Prejel PA5 PH
Nutroféli™ ST100
Nutroféli™ ST200
Nutroféli™ ST300